Rogerio Vivaldi Coelho's most recent trade in Crinetics Pharmaceuticals Inc was a trade of 3,000 Common Stock done at an average price of $40 . Disclosure was reported to the exchange on July 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Crinetics Pharma Inc | Rogerio Vivaldi Coelho | Director | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 02 Jul 2026 | 3,000 | 19,225 (0%) | 0% | 40 | 120,000 | Common Stock |
| Crinetics Pharma Inc | Rogerio Vivaldi Coelho | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2026 | 9,730 | 9,730 | - | - | Stock Option (Right to Buy) | |
| Crinetics Pharma Inc | Rogerio Vivaldi Coelho | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2026 | 5,925 | 22,225 (0%) | 0% | 0 | Common Stock | |
| Crinetics Pharma Inc | Rogerio Vivaldi Coelho | Director | Sale of securities on an exchange or to another person at price $ 36.08 per share. | 12 Mar 2026 | 4,477 | 16,823 (0%) | 0% | 36.1 | 161,530 | Common Stock |
| Crinetics Pharma Inc | Rogerio Vivaldi Coelho | Director | Sale of securities on an exchange or to another person at price $ 36.77 per share. | 12 Mar 2026 | 523 | 16,300 (0%) | 0% | 36.8 | 19,231 | Common Stock |
| Viatris | Rogerio Vivaldi Coelho | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 23,660 | 45,351 (0%) | 0% | 0 | Common Stock | |
| Viatris | Rogerio Vivaldi Coelho | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 23,660 | 0 | - | - | Restricted Stock Units | |
| Viatris | Rogerio Vivaldi Coelho | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2026 | 15,890 | 15,890 | - | - | Restricted Stock Units | |
| Viatris | Rogerio Vivaldi Coelho | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 1,175 | 46,526 (0%) | 0% | 0 | Common Stock | |
| Viatris | Rogerio Vivaldi Coelho | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 1,174 | 0 | - | - | Dividend Equivalent Units | |
| Crinetics Pharma Inc | Rogerio Vivaldi Coelho | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 10,350 | 10,350 | - | - | Stock Option (right to buy) | |
| Crinetics Pharma Inc | Rogerio Vivaldi Coelho | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 6,900 | 21,300 (0%) | 0% | 0 | Common Stock | |
| Viatris | Rogerio Vivaldi Coelho | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 23,660 | 23,660 | - | - | Restricted Stock Units | |
| Viatris | Rogerio Vivaldi Coelho | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 21,267 | 21,267 (0%) | 0% | 0 | Common Stock | |
| Viatris | Rogerio Vivaldi Coelho | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 21,267 | 0 | - | - | Restricted Stock Units | |
| Viatris | Rogerio Vivaldi Coelho | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 424 | 21,691 (0%) | 0% | 0 | Common Stock | |
| Viatris | Rogerio Vivaldi Coelho | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 423 | 0 | - | - | Dividend Equivalent Units | |
| Crinetics Pharma Inc | Rogerio Vivaldi Coelho | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | |
| Crinetics Pharma Inc | Rogerio Vivaldi Coelho | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 3,400 | 14,400 (0%) | 0% | 0 | Common Stock | |
| Viatris | Rogerio Vivaldi Coelho | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 21,267 | 21,267 | - | - | Restricted Stock Units | |
| Crinetics Pharma Inc | Rogerio Vivaldi Coelho | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 17,500 | 17,500 | - | - | Stock Option (right to buy) | |
| Crinetics Pharma Inc | Rogerio Vivaldi Coelho | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 6,000 | 11,000 (0%) | 0% | 0 | Common Stock | |
| Crinetics Pharma Inc | Rogerio Vivaldi Coelho | Director | Purchase of securities on an exchange or from another person at price $ 22.06 per share. | 08 Jun 2023 | 5,000 | 5,000 (0%) | 0% | 22.1 | 110,300 | Common Stock |
| Crinetics Pharma Inc | Rogerio Vivaldi Coelho | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 8,750 | 8,750 | - | - | Stock Option (right to buy) | |
| Crinetics Pharma Inc | Rogerio Vivaldi Coelho | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 35,000 | 35,000 | - | - | Stock Option (right to buy) |